Understand the source comparison
Cognitive & Nootropic Peptides Compared: Mechanism Comparison
The table below compares major cognitive and nootropic peptides across mechanism, administration route, effective dose ranges documented in peer-reviewed research, typical onset and duration, and bottom-line suitability for specific research applications. Sema
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The table below compares major cognitive and nootropic peptides across mechanism, administration route, effective dose ranges documented in peer-reviewed research, typical onset and duration, and bottom-line suitability for specific research applications.
- Semax
- Melanocortin & TrkB receptor agonist; increases BDNF, dopamine, serotonin turnover in prefrontal cortex
- Intranasal / ~70 min plasma half-life
- 300–600 mcg twice daily
- 30–90 min onset, 6–8 hr duration
- Acute cognitive tasks: attention, working memory, stress response. Requires continuous dosing.
- Selank
- Anxiolytic via GABAergic modulation; increases IL-10, reduces IL-6 (anti-inflammatory); enhances acetylcholine
- Intranasal / ~60 min
- 250–500 mcg 2–3× daily
- 20–60 min onset, 4–6 hr duration
- Anxiety reduction, stress resilience, learning under cognitive load. Best for short-term protocols.
- Cerebrolysin
- Neurotrophic peptide mix (NGF, FGF upregulation); promotes synaptic plasticity, dendritic branching
- IV/IM / complex kinetics
- 5–30 mL IV (210–1,260 mg peptides) 5–7×/week
- 7–14 days to measurable effect, persists weeks
- Neurodegeneration models, chronic cognitive decline, long-term synaptic density studies. Daily dosing required.
- Dihexa
- HGF receptor agonist (~7× amplification); promotes hippocampal neurogenesis, spine density
- Oral or subQ / 2–4 hr plasma, weeks receptor-level
- 1–5 mg daily for 7–10 days
- 10–14 days to peak, effects last 4–6 weeks
- Structural cognitive enhancement, long-term memory consolidation, age-related decline models. Single-cycle dosing.
- P21
- CNTF-derived fragment; increases hippocampal progenitor cell proliferation (BrdU+)
- SubQ / crosses BBB efficiently
- 1–5 mg 3–5×/week
- 5–7 days onset, 2–3 weeks duration
- Neurogenesis studies, cognitive recovery post-injury, hippocampal-dependent learning tasks.
- Pinealon
- Endothelial & neuronal peptide regulator; suggested neuroprotective, anti-aging effects
- Oral, subQ, or IM / not well characterized
- 10–20 mg daily for 10+ days
- Onset unclear, anecdotal long-term
- Exploratory neuroprotection models. Mechanism under-characterized; less suitable for mechanistic studies.
- Bottom-line interpretation: Semax and Selank are the workhorses for acute cognitive and anxiolytic research with rapid onset and short duration. Ideal when you need measurable effects within hours and can dose multiple times daily. Cerebrolysin and Dihexa target structural remodeling over weeks and are suited to chronic studies examining synaptic plasticity, neurogenesis, or age-related cognitive decline. These aren't 'stronger' than Semax; they address different biological timescales. P21 bridges the gap: neurogenesis effects measurable within a week, persisting 2–3 weeks post-dose. If your study examines acute cognitive performance, choose receptor agonists; if it examines structural brain changes, choose neurotrophic modulators. The mechanism determines the outcome. Not the milligram dose.